Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|April 10, 2023
Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposureRachel E Hudson, Torri D Metz, Robert M Ward, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2021
Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipientsKathleen M Job, Jessica K Roberts, Elena Y Enioutina, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|December 11, 2024
Optimal Dosing Recommendations of Clonidine in Pediatrics Using Physiologically Based Pharmacokinetic ModelingVenkata Yellepeddi, Sharlo Bayless, Madison Parrot, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
The Special Issue "The 20th Anniversary of Pharmaceuticals-Multi-Targeted Natural Products as Therapeutics" Editorial-Multi-Targeted Therapeutics from Natural Sources: What Do We Know?Elena Y Enioutina, Katheleen M Job, Catherine M Sherwin
Seminars in Perinatology|March 22, 2006
Drug disposition in the late preterm ("near-term") newbornRobert M Ward
Clinical Pharmacokinetics|March 25, 2018
Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic AnalysesSílvia M Illamola, Catherine M Sherwin, J G Coen van Hasselt
Frontiers in Pharmacology|March 29, 2020
The Reliability of Histamine Pharmacodynamic Response Phenotype Classification in Children With Allergic DiseaseShaun S Kumar, Xiaoxi Liu, Catherine M Sherwin, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 17, 2016
Population pharmacokinetic/pharmacodynamic modeling of histamine response measured by histamine iontophoresis laser DopplerXiaoxi Liu, Bridgette L Jones, Jessica K Roberts, et al.
British Journal of Clinical Pharmacology|July 11, 2022
Optimal dosing of enoxaparin in overweight and obese childrenAbdallah Derbalah, Stephen Duffull, Catherine M Sherwin, et al.
Cell Transplantation|October 18, 2019
A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple MyelomaSabarinath V Radhakrishnan, Michael Boyer, Catherine M Sherwin, et al.
Pageof 12